Physiomics Plc (LON:PYC – Get Free Report)’s stock price was up 4.1% during mid-day trading on Thursday . The company traded as high as GBX 0.78 ($0.01) and last traded at GBX 0.78 ($0.01). Approximately 1,979,196 shares traded hands during mid-day trading, an increase of 16% from the average daily volume of 1,709,716 shares. The stock had previously closed at GBX 0.75 ($0.01).
Physiomics Price Performance
The stock has a market cap of £1.59 million, a PE ratio of -13.83 and a beta of 1.69. The firm’s 50 day moving average price is GBX 0.69 and its two-hundred day moving average price is GBX 0.76.
Insider Buying and Selling at Physiomics
In other news, insider Peter Sargent bought 459,090 shares of Physiomics stock in a transaction that occurred on Thursday, November 7th. The shares were acquired at an average price of GBX 1 ($0.01) per share, with a total value of £4,590.90 ($5,753.01). Insiders own 4.18% of the company’s stock.
Physiomics Company Profile
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software.
Recommended Stories
- Five stocks we like better than Physiomics
- 3 Fintech Stocks With Good 2021 Prospects
- Top 3 Investment Themes to Watch for in 2025
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.